Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?

Literature DB >> 29346600

PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?

A Lavolé¹, A Guihot², M Veyri³, O Lambotte⁴, B Autran², N Cloarec⁵, G Le Garff⁶, T Flament⁷, J Cadranel⁸, J-P Spano⁹.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2018 PMID： 29346600 DOI： 10.1093/annonc/mdx817

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient's care behalf the CANCERVIH Group.

Authors: Aurelien Gobert; Jean-Philippe Spano; Jacques Cadranel
Journal: Med Oncol Date: 2018-12-05 Impact factor: 3.064

Review 2. Cancer immunotherapy of patients with HIV infection.

Authors: M Gonzalez-Cao; J Martinez-Picado; N Karachaliou; R Rosell; A Meyerhans
Journal: Clin Transl Oncol Date: 2018-11-17 Impact factor: 3.405

Review 3. Immunotherapy Use in Patients With Lung Cancer and Comorbidities.

Authors: Mitchell S von Itzstein; Amrit S Gonugunta; Helen G Mayo; John D Minna; David E Gerber
Journal: Cancer J Date: 2020 Nov/Dec Impact factor: 2.074

Review 4. The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?

Authors: Hui Chen; Maha Moussa; Marta Catalfamo
Journal: Front Immunol Date: 2020-07-02 Impact factor: 7.561

PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?

1. HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient's care behalf the CANCERVIH Group.

Review 2. Cancer immunotherapy of patients with HIV infection.

Review 3. Immunotherapy Use in Patients With Lung Cancer and Comorbidities.

Review 4. The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?

5. PD-1/PD-L1 pathway and angiogenesis dual recognizable nanoparticles for enhancing chemotherapy of malignant cancer.

Review 6. Immunotherapy in People With HIV and Cancer.

Review 7. Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs.

8. Targeted plasma proteomics reveals upregulation of distinct inflammatory pathways in people living with HIV.

Review 9. Targeting Immune Checkpoint Molecules to Eliminate Latent HIV.